Comparative pharmacokinetics of some injectable preparations containing ivermectin in dogs

Food and Chemical Toxicology

Volumn 48, Issue 8-9, 2010, Pages 2181-2185

  Eraslan, Gökhan ^a   Kanbur, Murat ^a   Liman, Bilal Cem ^a   Çam, Yücel ^a   Karabacak, Mürsel ^a   Altinordulu, Şule ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Comparative pharmacokinetics; Dog; Injectable preparation; Ivermectin

Indexed keywords

IVERMECTIN; ANTIPARASITIC AGENT; SOLUTION AND SOLUBILITY;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOG; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG EXPOSURE; DRUG FORMULATION; DRUG HALF LIFE; MALE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NONHUMAN; TIME TO MAXIMUM PLASMA CONCENTRATION; ANIMAL; COMPARATIVE STUDY; DOSE RESPONSE; HALF LIFE TIME; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INJECTION; MEDICINAL CHEMISTRY; REPRODUCIBILITY; SOLUTION AND SOLUBILITY; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTIPARASITIC AGENTS; AREA UNDER CURVE; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; HALF-LIFE; INJECTIONS; INJECTIONS, SUBCUTANEOUS; IVERMECTIN; MALE; PHARMACEUTICAL SOLUTIONS; REPRODUCIBILITY OF RESULTS;

ANIMALIA; CANIS FAMILIARIS;

EID: 77955050176     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2010.05.043     Document Type: Article

References (51)

1. Alvarez L., Lifschitz A., Entrocasso C., Manazza J., Mottier L., Borda B., Virkel G., Lanusse C. Evaluation of the interaction between ivermectin and albendazole following their combined use in lambs. J. Vet. Pharmacol. Ther. 2008, 31:230-239.
2. Atta A.H., Abo-Shihada M.N. Comparative pharmacokinetics of doramectin and ivermectin in sheep. J. Vet. Pharmacol. Ther. 2000, 23:49-52.
3. Baggot J.D. Clinical pharmacokinetics in veterinary medicine. Clin. Pharmacokinet. 1992, 22:254-273.
4. Bassissi M.F., Alvinerie M., Lespine A. Macrocyclic lactones: distribution in plasma lipoproteins of several animal species including humans. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2004, 138:437-444.
5. Baynes R.E., Payne M., Martin-Jimenez T., Abdullah A.R., Anderson K.L., Webb A.I., Craigmill A., Riviere J.E. Extralabel use of ivermectin and moxidectin in food animals. J. Am. Vet. Med. Assoc. 2000, 217:668-671.
6. Borges F.A., Cho H.S., Santos E., Oliveira G.P., Costa A.J. Pharmacokinetics of a new long acting endectocide formulation containing 2.25% ivermectin and 1.25% abamectin in cattle. J. Vet. Pharmacol. Ther. 2007, 30:62-67.
7. Campbell W.C., Fischer M.H., Stapley E.O., Schonberg G.A., Jacop T.A. Ivermectin: a potent new antiparasitic agent. Science 1983, 221:823-828.
8. Canga A.G., Sahagún Prieto A.M., Liébana M.J.D., Martínez N.F., Vega M.S., Vieitez J.J.G. The pharmacokinetics and metabolism of ivermectin in domestic animal species. Vet. J. 2009, 179:25-37.
9. Canga A.G., Sahagun A., Diez M.J., Fernandez N., Sierra M., Garcia J.J. Bioavailability of a commercial formulation of ivermectin after subcutaneous administration to sheep. Am. J. Vet. Res. 2007, 68:101-106.
10. Caumes E., Danis M. New indications of ivermectin. Rev. Med. Interne. 2001, 22:379-384.
11. Chittrakarn S., Janchawee B., Ruangrut P., Kansenalak S., Chethanond U., Kobasa T., Thammapalo S. Pharmacokinetics of ivermectin in cats receiving a single subcutaneous dose. Res. Vet. Sci. 2009, 86:503-507.
12. Clark J.N., Daurio C.P., Skelly B.J., Cheung E.N., Jeffcoat A.R. Pharmacokinetics of [3H]-ivermectin in the dog following oral administration of a beef-based chewable formulation containing ivermectin alone or in combination with pyrantel pamoate. J. Vet. Pharmacol. Ther. 1992, 15:217-220.
13. Craig T.M. Treatment of external and internal parasites of cattle. Vet. Clin. North Am. Food Anim. Pract. 2003, 19:661-678.
14. Daurio C.P., Cheung E.N., Jeffcoat A.R., Skelly B.J. Bioavailability of ivermectin administered orally to dogs. Vet. Res. Commun. 1992, 16:125-130.
15. Dryden M.W., Payne P.A. Preventing parasites in cats. Vet. Ther. 2005, 6:260-267.
16. El-Banna H.A., Goudah A., El-Zorba H., Abd-El-Rahman S. Comparative pharmacokinetics of ivermectin alone and a novel formulation of ivermectin and rafoxanide in calves and sheep. Parasitol. Res. 2008, 102:1337-1342.
17. El-Tahtawy A., Glue P., Andrews E.N., Mardekian J., Amsden G.W., Knirsch C.A. The effect of azithromycin on ivermectin pharmacokinetics-a population pharmacokinetic model analysis. PloS Negl. Trop. Dis. 2008, 2:1-10.
18. Fox L.M. Ivermectin: uses and impact 20 years on. Curr. Opin. Infect. Dis. 2006, 19:588-593.
19. Gokbulut C., Karademir U., Boyacioglu M., McKellar Q.A. Comparative plasma dispositions of ivermectin and doramectin following subcutaneous and oral administration in dogs. Vet. Parasitol. 2006, 135:347-354.
20. Gokbulut C., Karademir U., Boyacioglu M. Comparison of plasma pharmacokinetic profile of ivermectin following administration of subcutaneous injection (Baymec) and oral tablet (Efektin) in goats. J. Vet. Pharmacol. Ther. 2007, 30:489-491.
21. Gokbulut C., Karademir U., Boyacioglu M., McKellar Q.A. The effect of sesame and sunflower oils on the plasma disposition of ivermectin in goats. J. Vet. Pharmacol. Ther. 2008, 31:472-478.
22. Gokbulut C., Nolan A.M., McKellar Q.A. Plasma pharmacokinetics and faecal excretion of ivermectin, doramectin and moxidectin after oral administration in horses. Equine Vet. J. 2001, 33:494-498.
23. González A., Sahagun A.M., Diez M.J., Fernandez N., Sierra M., Garcia J.J. Pharmacokinetics of a novel formulation of ivermectin after administration to goats. Am. J. Vet. Res. 2006, 67:323-328.
24. Hotson I.K. The avermectins: a new family of antiparasitic agents. J. S. Afr. Vet. Assoc. 1982, 53:87-90.
25. Hugnet C., Lespine A., Alvinerie M. Multiple oral dosing of ketoconazole increases dog exposure to ivermectin. J. Pharm. Pharm. Sci. 2007, 10:311-318.
26. Imperiale F., Lifschitz A., Sallovitz J., Virkel G., Lanusse C. Comparative depletion of ivermectin and moxidectin milk residues in dairy sheep after oral and subcutaneous administration. J. Dairy Res. 2004, 71:427-433.
27. Jacobs D.E. Anthelmintics for dogs and cats. Int. J. Parasitol. 1987, 17:511-518.
28. Kaya S. Farmakokinetik. Veteriner Farmakoloji 2006, vol. 1:21-88. Medisan Yayi{dotless}nevi, Ankara. fourth ed.
29. Kaya S. Yuvarlak kurtlara etkiyen ilaçlar. Veteriner Farmakoloji 2007, vol. 2:510-539. Medisan Yayinevi, Ankara. fourth ed.
30. Kita K., Shiomi K., Omura S. Advances in drug discovery and biochemical studies. Trends Parasitol. 2007, 23:223-229.
31. Klotz U., Ogbuokiri J.E., Okonkwo P.O. Ivermectin binds avidly to plasma proteins. Eur. J. Clin. Pharmacol. 1990, 39:607-608.
32. Kojima K., Yamamoto K., Katae H., Nakanishi Y. Bioavailability of oral ivermectin in dog. Nippon. Juigaku. Zasshi. 1987, 49:899-900.
33. KuKanich B., Gehring R., Webb A.I., Craigmill A.L., Riviere J.E. Effect of formulation and route of administration on tissue residues and withdrawal times. J. Am. Vet. Med. Assoc. 2005, 227:1574-1577.
34. Lanusse C., Lifschitz A., Virkel G., Alvarez L., Sánchez S., Sutra J.F., Galtier P., Alvinerie M. Comparative plasma disposition kinetics of ivermectin, moxidectin and doramectin in cattle. J. Vet. Pharmacol. Ther. 1997, 20:91-99.
35. Lespine A., Dupuy J., Alvinerie M., Comera C., Nagy T., Krajcsi P., Orlowski S. Interaction of macrocyclic lactones with the multidrug transporters: the bases of the pharmacokinetics of lipid-like drugs. Curr. Drug. Metab. 2009, 10:272-288.
36. Lifschitz A., Pis A., Alvarez L., Virkel G., Sanchez S., Sallovitz J., Kujanek R., Lanusse C. Bioequivalence of ivermectin formulations in pigs and cattle. J. Vet. Pharmacol. Ther. 1999, 22:27-34.
37. Lifschitz A., Sallovitz J., Imperiale F., Pis A., Jauregui Lorda J., Lanusse C. Pharmacokinetic evaluation of four ivermectin generic formulations in calves. Vet. Parasitol. 2004, 119:247-257.
38. Lifschitz A., Virkel G., Pis A., Imperiale F., Sanchez S., Alvarez L., Kujanek R., Lanusse C. Ivermectin disposition kinetics after subcutaneous and intramuscular administration of an oil-based formulation to cattle. Vet. Parasitol. 1999, 86:203-215.
39. Lo P.K., Fink D.W., Williams J.B., Blodinger J. Pharmacokinetic studies of ivermectin: effects of formulation. Vet. Res. Commun. 1985, 9:251-268.
40. Maeda H., Brandon M., Sano A. Design of controlled-release formulation for ivermectin using silicone. Int. J. Pharm. 2003, 261:9-19.
41. Meinke P.T. Perspectives in animal health: old targets and new opportunities. J. Med. Chem. 2001, 44:641-659.
42. Miller J.A., Oehler D.D., Pound J.M. Delivery of ivermectin by injectable microspheres. J. Econ. Entomol. 1998, 91:655-659.
43. Okonkwo P.O., Ogbuokiri J.E., Ofoegbu E., Klotz U. Protein binding and ivermectin estimations in patients with onchocerciasis. Clin. Pharmacol. Ther. 1993, 53:426-430.
44. Pérez R., Godoy C., Palma C., Cabezas I., Muñoz L., Rubilar L., Arboix M., Alvinerie M. Plasma profiles of ivermectin in horses following oral or intramuscular administration. J. Vet. Med. A Physiol. Pathol. Clin. Med. 2003, 50:297-302.
45. Prichard R.K., Roulet A. ABC transporters and beta-tubulin in macrocyclic lactone resistance. prospects for marker development. Parasitology 2007, 134:1123-1132.
46. Rohrer S.P., Evans D.V. Binding characteristics of ivermectin in plasma from collie dogs. Vet. Res. Commun. 1990, 14:157-165.
47. Scott E.W., McKellar Q.A. The distribution and some pharmacokinetic parameters of ivermectin in pigs. Vet. Res. Commun. 1992, 16:139-146.
48. Shumaker R.C. PKCALC a Basic interactive computer program for statistical and pharmacokinetic analysis of data. Drug Metabol. Rev. 1986, 17:331-348.
49. Sutherland I.H. Veterinary use of ivermectin. Acta Leiden 1990, 59:211-216.
50. Vercruysse J., Deprez P., Everaert D., Bassissi F., Alvinerie M. Breed differences in the pharmacokinetics of ivermectin administered subcutaneously to Holstein and Belgian Blue calves. Vet. Parasitol. 2008, 152:136-140.
51. Wagner J.G. Fundamentals of clinical pharmacokinetics 1975, Drug Intelligence Pub. Inc., Hamilton Press, IL, USA, pp. 57-128. first ed.